PetMed Express, Inc. PETS

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

The label

Distribution

read at $1.68

PetMed Express, Inc. holds its Distribution at $1.68.

PHPhase · the trend structure carries the Distribution label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate

edge confirmed
edge broken
edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-05-22
Phase	Distribution · caution
Quantitative state	The statistical read favours the sellers, held for 89 days
Price	$1.68
Valuation	0.00 trailing · -71.92 forward price to earnings
Values screen	FAIL
Beta	N/A

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Forward P/E	-71.9x
Trailing P/E	0.0x
Revenue growth	-21.7% revenue is shrinking
Profit margin	-34.7% currently unprofitable
Return on equity	-100.6% not currently earning a positive return on equity
Debt to equity	0.02 minimal debt — a conservative balance sheet
Market cap	$46M

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & how to trade · wherever in the world you are

PETS trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The trader read · the latest dated commentary

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2. Entered 2026-07-18 · Markdown

The dated journal · newest first, never edited

2026-07-18 Markdown $1.68 +0.0% Entry 3

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2.

2026-07-03 Markdown $1.68 +0.0% Entry 2

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markdown $1.68 Entry 1

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The insider ledger · Form 4 filings, as filed

Most recent filings · PETS
Date	Insider	Title	Shares	Value
2025-10-30	FULGONI GIAN M	Director	33,846	·
2025-10-30	MENNEN JUSTIN L.	Director	33,846	·
2025-10-30	LACAMP JAMES	Director	34,866	·
2025-10-30	SOLIVAN LEAH A.	Director	33,846	·
2025-10-30	BATUSHANSKY PETER	Director	33,846	·
2025-10-30	KRULIK DOUGLAS	Chief Financial Officer	20,000	·
2025-09-09	KRULIK DOUGLAS	Officer	10,000	·
2025-08-13	SILVERCAPE INVESTMENTS LTD.	Beneficial Owner of more than 10% of a Class of Security	101,000	$320,170
2025-08-01	SILVERCAPE INVESTMENTS LTD.	Beneficial Owner of more than 10% of a Class of Security	118,200	$379,422
2025-07-21	NINA CAPITAL HOLDINGS INC	Beneficial Owner of more than 10% of a Class of Security	25,000	$87,425

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
Period	Price then	Price return	Divs per share	$1,000 became	Total return
1 month	$2.26	-23.9%	·	$761	-23.9%
2 months	$2.30	-25.2%	·	$748	-25.2%
3 months	$2.43	-29.2%	·	$708	-29.2%
6 months	$2.98	-42.3%	·	$577	-42.3%
1 year	$4.19	-59.0%	·	$411	-59.0%
2 years	$4.20	-59.1%	·	$410	-59.1%
3 years	$14.61	-88.2%	$0.30	$138	-86.2%
5 years	$28.70	-94.0%	$2.70	$154	-84.6%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever PETS does next, these words stay.

PetMed Express, Inc. · PETS · Distribution · $1.68
Recorded 2026-05-22 · before the outcome · scored mechanically

All of today's entries See the running score

PetMed Express, Inc. PETS

This entry now belongs to the ledger. Whatever PETS does next, these words stay.

Before you go